Clinical outcomes of coronavirus disease 2019 in liver transplant recipients

Table 1 General characteristics of cases and controls

Characteristics	Cases, n = 39	Controls, n = 78
Age, mean ± SD	55.23 ± 13.51	55.32 ± 13.65
Sex, males (%)	26 (66.7)	52 (66.7)
Race, n (%)
Caucasian	31 (79.5)	45 (57.7)
African American	3 (7.7)	11 (14.1)
Hispanic	3 (7.7)	14 (17.9)
Asian	0 (0.0)	2 (2.6)
Other/unknown	2 (5.1)	6 (7.7)
Presence of
Diabetes, n (%)	17 (43.6)	15 (19.2)
Hypertension, n (%)	23 (59)	30 (38.5)
Obesity, n (%)	14 (35.9)	28 (35.9)
Congestive heart failure, n (%)	3 (7.7)	6 (7.7)
Chronic kidney disease or hemodialysis, n (%)	14 (35.9)	8 (10.3)

Table 2 Characteristics of cases pertinent to liver transplantation

Characteristics	n	%
Additional renal transplantation
Yes	6	15.4
No	33	84.6
Duration of liver transplantation
< 1 yr	3	7.7
1 to < 5 yr	13	33.3
5 to 10 yr	12	30.8
> 10 yr	11	28.2
Etiology of end-stage liver disease prior to liver transplantation
Alcohol use	7	17.9
Chronic hepatitis C infection	8	20.5
Nonalcoholic fatty liver disease	5	12.8
Primary sclerosing cholangitis	4	10.3
Other	15	38.5
Current status of liver transplant
Working	33	84.6
Failed/cirrhotic	6	15.4

Table 3 Death due to coronavirus disease 2019

Liver transplant recipient	Death due to COVID-19		Total	Odds ratio with 95% confidence interval	Two-sided P value
	Yes	No
Yes	2	37	39	2.04 (0.14–29.17)	0.6
No	2	76	78
Total	4	113	117

COVID-19: Coronavirus disease 2019.

Table 4 Hospitalization due to coronavirus disease 2019

Liver transplant recipient	Hospitalization due to COVID–19		Total	Odds ratio with 95% confidence interval	Two-sided P value
	Yes	No
Yes	12	27	39	1.38 (0.59–3.24)	0.46
No	19	59	78
Total	31	86	117

COVID-19: Coronavirus disease 2019.